Other languages Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Market Closed - Nyse Other stock markets 04:00:02 2024-04-30 pm EDT			Pre-market 07:00:20 am
43.94 ^USD	-1.57%		44.32	+0.86%

Apr. 30	Global markets live: Adidas, Mercedes, McDonalds, Eli Lilly, PayPal, MicroStrategy, Tesla...
Apr. 30	A flurry of corporate results ahead of the Fed's rate decision

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : Tesla, Snap, Alphabet, Microsoft, Anglo American...	Apr. 30
Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb	Apr. 30
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion	Apr. 30
Après Microsoft, Alphabet, Tesla et Apple, Amazon doit faire le job	Apr. 30
En Direct des Marchés : Thales, Stellantis, Capgemini, Atos, VusionGroup, Orpea, Adidas, HSBC...	Apr. 30
Borsa di Italia: Dopo Microsoft, Alphabet, Tesla e Apple, Amazon deve fare il suo lavoro	Apr. 30
IN DIRETTA DAI MERCATI: Tenaris, Generali, Caixabank, Eni, Leonardo, Stellantis, HSBC, Webuild, Samsung, Coca-Cola, Tesla, Caterpillar...	Apr. 30
EN DIRECTO DESDE LOS MERCADOS: BBVA, Santander, Caixabank, Soltec, Ercros, Grifols, HSBC, Samsung, Coca-Cola, Tesla, Caterpillar...	Apr. 30
Bolsa de Madrid: Tras Microsoft, Alphabet, Tesla y Apple, Amazon debe hacer su trabajo	Apr. 30
J&J, Bristol Myers lose challenges to US drug price negotiation program	Apr. 29
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases	Apr. 29
S&P 500 Q1 earnings estimated growth improves; stocks up for week	Apr. 26
Bristol-Myers Squibb Says European Regulator Recommends Approval of Bladder Cancer Combination Therapy	Apr. 26
Bristol Myers : avis favorable du CMHP pour Opdivo	Apr. 26
CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb's Opdivo in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma	Apr. 26
Sector Update: Health Care Stocks Decline Late Afternoon	Apr. 25
Sector Update: Health Care Stocks Drop in Afternoon Trading	Apr. 25
Sector Update: Health Care	Apr. 25
Bristol-Myers Squibb Swings to Q1 Non-GAAP Loss, Revenue Rises; Provides 2024 Guidance -- Shares Fall	Apr. 25
STATI UNITI. - I titoli da tenere d'occhio a Wall Street (aggiornamento)	Apr. 25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

January 09, 2024 at 01:06 pm EST